Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $94.8900 (1.09%) ($94.8900 - $95.0200) on Wed. Oct. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 55 | Latest Price | $94.8900(1.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.2% a day on average for past five trading days. | Weekly Trend | LGND advances 2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(49%) IWN(49%) IWO(49%) IWC(46%) IBB(44%) | Factors Impacting LGND price | LGND will decline at least -1.3% in a week (0% probabilities). VXX(-16%) UUP(-15%) TBT(-7%) UNG(-6%) VIXM(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $89.49(6.03%) | 10 Day Moving Average | $85.58(10.88%) | 20 Day Moving Average | $87.53(8.41%) | To recent high | -11.9% | To recent low | 22.2% | Market Cap | $1.525b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |